Authors

Overview

Team 9 “discovering new biomarkers” of the Canadian Consortium on Neurodegeneration in Aging (CCNA) is co-lead by Dr Roger Dixon, department of Psychology, University of Alberta, and Dr Pierre Bellec, department of Psychology, University of Montreal. The generation of imaging biomarkers using standardized pipelines is one of the core objective of the CCNA biomarkers team, and involves only a subset of investigators, listed below. These imaging biomarkers cover all imaging modalities collected as part of the “comprehensive assessment of neurodegeneration in aging” (COMPASS-ND) cohort, following the Canadian Dementia Imaging Protocol CDIP.

Funding

The Canadian consortium on neurodegeneration in aging is supported by an infrastructure and operating grant from the CIHR (Grant no. CNA-137794) and the following partners: Alberta Prion Research Institute, Alzheimer’s Research UK, Alzheimer Society of Canada, Canadian Nurses Foundation, Fonds de recherche du Québec – Santé, Michael Smith Foundation for Health Research, New Brunswick Health Research Foundation, Nova Scotia Health Research Foundation, Ontario Brain Institute, Pfizer Inc., Robin and Barry Picov Family Foundation, Sanofi, Saskatchewan Health Research Foundation, Women’s Brain Health Initiative. The CNNA imaging biomarkers team receives additional support from Alberta Innovates and the Courtois foundation.

Standardized Imaging Biomarkers subteam

In alphabetical order:

  • Dr. AmanPreet Badhwar, principal investigator (CRIUGM, University of Montreal, Québec, CA).

  • Dr. Christian Beaulieu, principal investigator (University of Alberta, Alberta, CA).

  • Dr. Pierre Bellec, co-lead (CRIUGM, University of Montreal, Québec, CA).

  • Dr. Faisal Beg, principal investigator (Simon Fraiser University, British Columbia, CA).

  • Mr. Arnaud Boré, data scientist (CRIUGM and Sherbrooke University, Quebec, CA).

  • Dr. Mallar Chakravarti, principal investigator (Douglas Institute, McGill University, Quebec, CA).

  • Dr. Louis Collins, principal investigator (Montreal Neurological Institute, McGill University, Quebec, CA).

  • Dr. Maxime Descoteaux, principal investigator (Sherbrooke University, Quebec, CA).

  • Dr. Roger Dixon, co-lead (University of Alberta, Alberta, CA).

  • Dr. Simon Duchesne, principal investigator (Cervo Centre, Laval University, Quebec, CA).

  • Dr. Desirée Lussier, post-doctoral fellow (CRIUGM, University of Montreal, Quebec, CA).

  • Dr. Eric Smith, principal investigator (University of Calgary, Alberta, CA).

  • Mr. Loic Tetrel, data scientist (CRIUGM, Quebec, CA).